The California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research projects to advance stem cell and gene therapy treatments for conditions ranging from neurodegenerative diseases to blood cancers, HIV/AIDS, and vision loss. The awards will support six projects in the Agency’s clinical program, which funds eligible stem cell and gene therapy-based projects … Continue reading CIRM invests $50 million in clinical research, including trial for vision loss
Month: July 2023
Kevin Xu joins CIRM board
CIRM has appointed Kevin Xu to its Independent Citizens’ Oversight Committee, the agency’s governing board. Xu is CEO of MEBO International, which manages “Human Body Regenerative Restoration Science,” and Skingenix, a California‑based regenerative drug‑development company. “It is a privilege to join CIRM’s board,” Xu said. “I look forward to working with experts dedicated to advancing … Continue reading Kevin Xu joins CIRM board